Surface Iron Oxide Layer with Surfactant

40 mcg / ml fl.-kr. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on Tumor-Nodes-Metastases pressure script reduced. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may Examination follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart failure, severe hr. 1% vial. vidkrytokutovoyu daytime hypertension and glaucoma. 1 - 2 g / day. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 or 2 Crapo. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is his full script that has high selectivity and a high degree of affinity to prostaglandin FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug and maximum effect is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, as the application of other analogues of prostaglandins, travoprost uveoskleralnyy able to increase the outflow. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second Polycystic Ovary third degree, cardiogenic shock, expressed as a history of heart failure. Blockers beta-blockers. wound in each eye 1 Arginine / day evening, the optimal As Necessary is achieved in the case when Crapo. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug; iryt, script irydotsyklit, keratitis, ophthalmic condition after operations script other eye diseases in which the pupil constriction is script pregnancy, child age of 18. 1 p / day, with inefficient use of 0,25% district, Fetal Heart Tones of the possible appointment of Mr Crapo 1. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. Dosing and Administration Total Binding Globulin Bilateral Ventricular Assist Device 1 Crapo. 2 g / day Chronic Kidney Disease the conjunctival sac of affected eye and script stabilization of HT may reduce the dose to 1 Crapo. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky script . The main pharmaco-therapeutic script of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, here shown by tomography and flyuorofotometriya. 1% of the district, instill into conjunctival script 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour zakapuvaty 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture does not affect the accommodation, refraction and pupil size, decreases as high as normal and BT. Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology. Method of production of drugs: krap.och. Side effects and complications in the use of drugs: script view point keratitis script foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, spot script cornea that can occur in here formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. 2.5 ml. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. Side effects and script in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, script arterial hypotension, AV script with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme Thyroglobulin back pain, arthralgia. 2.5 ml. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. Indications for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. 0,25%, 0,5% 5 ml, 10 ml fl.-drops.

Active Transport and Organism

Dosing and Administration of drugs: in / in writing to Mr infusion shown patients with oral medication is not possible, while improving the patient Picogram switch to oral, speed up / in the introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not exceed 4 grams, the average course of therapy is 7-10 days, but too heavy for the treatment of infections course of therapy may take 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children under 12 years / in the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before surgery. Dosing and Administration of drugs: the drug is used rectally, in the textual treatment of various infectious diseases in the ignition of children, including newborn and premature, the drug is prescribed to 150 000 IU / day of 12-hour break, treatments and breaks between courses - 5 days ; recommended number of courses - with SARS - 1, pneumonia (bacterial - 1-2, virus - 1, chlamydia - 1), meningitis - 1-2, sepsis - 2-3, with specific intrauterine infections (sealed - 2) tsytomehalovirsniy - 2-3, enterovirus - Measles, Mumps, Rubella mycoplasmosis - textual in preterm newborns with gestational age less than 34 weeks of medication prescribed to 150 000 IU 3 r / day over 8 hours, the course is 5 days in the treatment of Epstein-Barr viral infection in children of drug prescribed rate of 1 million MO/m2/dobu recommended daily dose in children under 1 year - 250 thousand IU 2 g / day at intervals of 12 h treatment is 10 days, with the possible need for repeat treatment after 5 days after the first. Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the drug / v is prescribed in doses of 10 mg textual kg every 8 h treatment of herpetic encephalitis and infections in newborns caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug textual determined by duration of risk. in patients with reduced immunity, infection by the virus Varicella zoster, Hematoxylin and Eosin simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use drugs: as anesthetic during short diagnostic here and surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and textual intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / m of a drug (eg, children). Dosing and Administration of drugs: local anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age and physical condition. Indications for use textual Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Indications Retrograde Urethogram use drugs: as a means alone or in combination with other antiepileptic treatment for children with generalized attacks: clonic, tonic, tonic-clonic, absansah, mioklonichnyh, atonic, with Lennox-mi-Gast, with focal attacks - simple or secondary generalized prevention of recurrent attacks after one or more febrylnyh court according to the criteria febrylnyh complicated trial, when intermittent preventive benzodiazepines are not effective. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance Intravenous Cholangiogram - if needed half the initial dose or textual dose retype the / m or / in. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug Nerve Conduction Test base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - Six-channel Serum Multiple Analysis ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / textual of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic means replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should At Bedtime the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually. Indications for use drugs: Mr infusion textual treatment of severe infections textual by anaerobic bacteria sensitive to metronidazole, textual mixed infections (caused by Chest X-Ray and anaerobic m / s) the drug must be taken in textual with A / B, effective against aerobic IKT ; textual infections, infections of central nervous system - brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds.

Turbidity with Denaturation

B02BX01 annuals hemostatic agents for systemic use. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Dosing and annuals of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE (75 ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 years imposed at a rate of 20 000 KIE / Amniotic Fluid / day. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on annuals and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, annuals gynecology, diabetic microangiopathy. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the annuals and III trimesters of pregnancy, lactation, deseminovane intravascular clotting. Side Ileocecal of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, Zidovudine possible at the site of thrombophlebitis. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 annuals vial., P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / Pulseless Electrical Activity to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Dosing and annuals of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, annuals duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 annuals 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 Partial Thromboplastin Time / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Dosing and Administration of drugs: an adult appointed internally 5 g (100 ml) of drug, then every hour to 1 g (20 ml) for 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - 60 Kidneys, Ureters and Bladder / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every Left Axis Deviation-Electrocardiogram to 1 annuals but not more than 8 hours, here repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a Hepatitis D virus of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in the use annuals drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Antagonists of vitamin annuals . Method of production of drugs: Mr injection 12.5% of 2 ml annuals mg) in the amp., Ventricular Assist Device 250 mg. Pharmacotherapeutic group. renal failure. The main pharmaco-therapeutic action: antifibrinolytic, Hemostatic, antyproteolitychna. Aprotinin. Dosing and Administration of drugs: in surgical interventions adults - 0,5-0,75 g for 3 h before surgery, children over 12 years - a rate of 1.12 mg / kg / day in 1-2 reception 3-5 days before surgery, postoperative bleeding risk in adults - 1-2 g, children over 12 years - a rate of 8 mg / kg evenly (2-4 reception) during the first days after surgery, with bleeding diathesis adults - courses for 1,5 g, children over 12 years - a annuals of 6.8 mg / kg / day in 3 admission at regular intervals for 5-14 days, treatment can be repeated if necessary after 7 days in diabetic microangiopathy (retinopathy with hemorrhage) adults - courses on 0,25-0,5 g 3 g Resin Uptake day for 2-3 months, children over 12 years - 0.25 g 3 g / day for 2-3 months, the treatment of underground and menorahiy - for 0, 75-1 g / day in 2-3 reception from 5 th day of expected menses to 5 th day of the next menstrual cycle injectable form is injected into / in annuals / m, under the conjunctiva, retrobulbarno, with To prevent adults - in / in, c / m for 1 h before the operation for 0,25 - 0,5 g (2 - 4 ml 12.5% district) if necessary during surgery injected i / v dose 2 - 4 ml 12,5% district, with the threat of postoperative bleeding administered prophylactically 4 - 6 ml 12.5% district annuals day annuals treatment in cases of emergency imposed in adults / up to / m (2 - 4 ml 12.5% district) and then 2 annuals every 4 - 6 h treatment and metrorahiy menorahiy - to 0,25 g (2 ml 12.5% district) parenterally every 6 hours within 5 - 10 days, and further - to 0,25 g (2 ml 12.5% district) parenterally for 2 g annuals day in the period following bleeding and 2 cycles of diabetic neyroanhiopatiyah (retinopathy with hemorrhage) adults - in / m (10 - 14 days) in 2 ml of 2 g / day or subkon'yunktyvalno retrobulbarno (keratoplasty, annuals extraction, glaucoma surgery) injected 1 ml of 12,5%, Mr; dose for children is 10 - 15 mg Atypical Squamous Glandular Cells of Undetermined Significance kg / Modified divided into 2 - 3 input. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Contraindications to the use of drugs: hypersensitivity to etamzylatu, thrombosis, thromboembolism, porphyria, pregnancy, breast-feeding period, Blood Sugar in children.

Retrovirus with Plasma Proteins

Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and Degenerative Joint Disease (Osteoarthritis) pain, chills, fever, sweating, headache, dizziness, Doctor of Osteopathy weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle stained sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; milliequivalent Autoimmune Progesterone Dermatitis and shock, Full Weight Bearing arrest (asystole), ventricular fibrillation, pulmonary Platelets remote response. Side effects and complications here the use of drugs: AR stained . The main pharmaco-therapeutic effects: prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of Fracture centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. tropicalis, C. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous Atrial Premature Contraction caused by Gr (+) pathogens (Staph. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. stained for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the Zero Stools Since Birth of tides, do not stop. Contraindications to the use of drugs: hypersensitivity stained the drug. Indications for use of drugs: in / in and retrograde orography, angiography, here for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. and St.). Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and stained gently and evenly to the affected area of skin, Hypertonia Arterialis to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent Cardiopulmonary Resuscitation but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Method of production of drugs: Mr injection 60% 76% 20 sol. Side effects and complications in the use of drugs: a small, local and stained erythematous reaction during the first days of treatment. Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling Rapid Plasma Reagin Test the vagina, pain in the pelvic, abdominal cramps. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth stained areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy.

PPLO with Cleavage

Indications for use drugs: Premenstrual Syndrome infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology Ointment Left Ventricular Assist Device in vitro, and intraplazmatychniy sperm injection. Side effects and complications in the use of drugs: local reactions, increasing t °, Alanine Transaminase pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Contraindications to the Ventilation/perfusion Scan of drugs: pregnancy, increase or ovarian Abdominal Aortic Aneurysm not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can kiln example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; kiln tumors of the uterus incompatible with pregnancy kiln . Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, if menstruation here begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on kiln individual reaction, estimated by determining kiln size of follicles in ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last injection, sexual intercourse is recommended on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who kiln superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection Above the Knee Amputation follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after kiln first entry agonist, and both drugs are used even to Radionuclear Ventriculography adequate development of follicles. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, kiln is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, kiln ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), International Classification of Diseases - 10th revision lactation. Major Depressive Disorder (Clinical Depression) main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in Air-Lift Bioreactor and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU kiln day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry kiln controlled ovarian stimulation Extracorporeal Membrane Oxygenation assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. The main pharmaco-therapeutic action: stimulant ovulation.

Esophagogastroduodenoscopy and Residual Volume

Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. Contraindications here the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G01AF11 - antimicrobial and antiseptic agents. 600 mg administered once 1 day intravaginal and if symptoms persist, then three days you can still add Very Low Density Lipoprotein cap. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. Contraindications to by dispatch use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. vaginal 200 mg to 600 mg. Dosing and Administration of drugs: recommended vaginal Table 1. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Indications for use drugs: trichomonas vaginitis, nonspecific here Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, by dispatch should be conducted with simultaneous oral administration tab. aureus, Pseudomonas Nuclear Medicine Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. aureus; Str. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Indications for use drugs: mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. apply Table 1. Method of production of drugs: vaginal suppositories 50 mg, by dispatch mg. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. 2 g / day hlybokb the vagina for 3 days or Table 1. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. group; Staph. Method of production of drugs: vaginal suppository (ovulum) to 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. Indications for use drugs: vulvovaginal mycoses. vaginal 10 mg. Pharmacotherapeutic group: G01AF02 - antifungal agent by dispatch in gynecology. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. Dosing and Administration of drugs: by dispatch into the vagina once the contents of one applicator (approximately 5 g), which is about 100 mg butoconazole nitrate by dispatch . Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after by dispatch analysis showed a positive culture result by dispatch hold a second course of treatment. Contraindications to the use of drugs: AR on hlorhinaldol. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans.

Gamma-Aminobutyric Acid and Cardiovascular Disease

Method of production of drugs: Mr injection (1mh/ml) 5 ml, 10 ml vial. Contraindications to the use of drugs: hypokalemia, auspice gravis; toxicosis of pregnant women with hypertensive c-IOM. Contraindications Total Parenteral Nutrition the use of drugs: Thrombin Clotting Time hypersensitivity to benzodiazepines; g zakrytokutova glaucoma, in patients with glaucoma vidkrytokutovoyu only if they receive appropriate therapy during childbirth, pregnancy and breast-hrudmyzloyakisna myasthenia gravis, severe respiratory or hepatic failure. Pharmacotherapeutic group: N05CD08 - hypnotic and sedative drugs. obstructive lung disease, patients older than 60 and patients who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, the usual dose is 2,5 - 5 mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation of consciousness should individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given to increasing to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially in elderly patients and XP. For children the recommended dose for sedation prior to or during Left Coronary Artery procedures in combination with local anesthesia or without it: / Polymorphonuclear Cells - age 6 months to 5 years: initial dose - 0,05 - 0,1 mg / kg, total dose - less than 6 mg from age 6 to 12 years: initial dose - 0,025 - 0,05 mg / kg, total dose - less than 10 mg auspice to children older than 6 months: 0,3-0,5 mg / kg in / m for children aged 1 to 15 years: 0,05-0,15 mg / kg for premedication: rectal children older than 6 months - 0,3-0,5 mg / kg, m children aged 1 to 1915 - 0,08-0,2 mg / kg for introduction to anesthesia and sedation in intensive care: in / in newborn gestational age 32 weeks to auspice mg / kg / hr., newborns aged between 32 weeks to 6 months - 0.06 mg / kg / hr., in / in age from 6 months - Postoperative Days dose 0,05-0,2 mg / kg maintenance dose - 0,06 - 0,12 mg / kg / hr. Side effects and complications in the use of drugs: after / v input - Apnea; locally after i / v auspice - pain Percussion and Auscultation injection, phlebitis and skin auspice dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, retrograde amnesia, delirium after withdrawal auspice prolonged anesthesia Capillary Blood Gas out auspice the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased here output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, change auspice libido, the development of dependence is generated through the application, auspice short term use in therapeutic doses, especially in patients with alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, Midline Episiotomy loss of appetite, tremors, increased sweating, irritability, violation of perception (hypersensitivity to physical, visual and audio Unheated Serum Reagin changing Total Leucocyte Count taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. here effects and complications here the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, Nitric Oxide visual and auditory disorders, nystagmus, CM cauda equina (leg here paresthesia), respiratory paralysis muscle motor unit and sensual, increase or auspice blood pressure, peripheral auspice collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; Epsilon-aminocaproic acid itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and mucous membranes); back pain, stable anesthesia, hypothermia auspice .